Cingulate Inc. (NASDAQ:CINGW) Short Interest Update

Cingulate Inc. (NASDAQ:CINGW) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totaling 800 shares, an increase of 60.0% from the November 30th total of 500 shares. Based on an average daily volume of 45,078 shares, the short-interest ratio is currently 0.0 days. Based on an average daily volume of 45,078 shares, the short-interest ratio is currently 0.0 days.

Cingulate Stock Performance

Shares of NASDAQ:CINGW opened at $0.06 on Tuesday. The stock’s 50-day moving average is $0.04 and its 200 day moving average is $0.06. Cingulate has a 1 year low of $0.02 and a 1 year high of $0.18.

Cingulate Company Profile

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.